da Fonseca Ana Carolina Proença, Abreu Gabriella de Medeiros, Palhinha Lohanna, Zembrzuski Verônica Marques, Campos Junior Mario, Carneiro João Regis Ivar, Nogueira Neto José Firmino, Magno Fernanda Cristina C Mattos, Rosado Eliane Lopes, Maya-Monteiro Clarissa Menezes, de Cabello Giselda Maria Kalil, Cabello Pedro Hernán, Bozza Patricia Torres
Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Diabetes Metab Syndr Obes. 2021 Jan 6;14:11-22. doi: 10.2147/DMSO.S267202. eCollection 2021.
Brain-derived neurotrophic factor (BDNF) is a pro-survival factor in the brain that also regulates energy balance. loss-of-function point mutations are responsible for haploinsufficiency, causing severe early-onset obesity. Up to date, only a few studies have sequenced this gene to search for rare mutations related to obesity. In this study, we aimed to investigate the prevalence of variants in a cohort of adults with severe obesity from Brazil.
This study comprised 201 adults with severe obesity (BMI ≥ 35.0 kg/m) with onset during childhood- or adolescence/youth. As controls, 73 subjects with normal weight (18.5 ≤ BMI ≤ 24.9 kg/m) were selected. The exclusion criteria were pregnancy, lactation, the use of medication to lose or gain weight, and the presence of symptoms suggestive of syndromic obesity (only for the case group). The coding region of the gene was screened by Sanger sequencing. Demographic, anthropometric, and blood pressure parameters were obtained from the participants as well as serum hormone and cytokines concentrations and biochemical values.
As a result, three missense variants [p.(Thr2Ile), p.(Val66Met), and p.(Arg209Gln)] and four synonymous variants (p.Leu107=, p.Thr149=, p.Ala150=, and p.Ser213=) were identified. The p.(Arg209Gln) was predicted as pathogenic by all in silico algorithms used and was not observed in the control group. The individuals carrying the p.(Val66Met) mutated allele had higher waist circumference, HDL-cholesterol and MCP1 levels, and reduced risk of developing metabolic syndrome.
We observed that the common p.(Val66Met) variant has influenced waist circumference, HDL-cholesterol, and MCP1 levels. This polymorphism has also a protective effect on metabolic syndrome susceptibility. Additionally, we described for the first time a rare potentially pathogenic variant in a Brazilian patient with severe obesity and childhood-onset.
脑源性神经营养因子(BDNF)是一种在大脑中具有促生存作用的因子,同时也调节能量平衡。功能丧失性点突变导致单倍剂量不足,引发严重的早发性肥胖。截至目前,仅有少数研究对该基因进行测序以寻找与肥胖相关的罕见突变。在本研究中,我们旨在调查来自巴西的重度肥胖成年人群队列中该基因变异的发生率。
本研究纳入了201名童年期或青少年/青年期起病的重度肥胖成年人(BMI≥35.0kg/m²)。作为对照,选取了73名体重正常的受试者(18.5≤BMI≤24.9kg/m²)。排除标准包括妊娠、哺乳期、使用减肥或增肥药物以及存在提示综合征性肥胖的症状(仅针对病例组)。通过桑格测序法对该基因的编码区进行筛查。从参与者中获取人口统计学、人体测量学和血压参数,以及血清激素、细胞因子浓度和生化值。
结果共鉴定出3个错义变异[p.(Thr2Ile)、p.(Val66Met)和p.(Arg209Gln)]和4个同义变异(p.Leu107=、p.Thr149=、p.Ala150=和p.Ser213=)。所有使用的计算机算法均预测p.(Arg209Gln)为致病性变异,且在对照组中未观察到。携带p.(Val66Met)突变等位基因的个体腰围、高密度脂蛋白胆固醇和MCP1水平较高,发生代谢综合征的风险降低。
我们观察到常见的p.(Val66Met)变异影响了腰围、高密度脂蛋白胆固醇和MCP1水平。这种多态性对代谢综合征易感性也具有保护作用。此外,我们首次在一名巴西重度肥胖且童年期起病的患者中描述了一种罕见的潜在致病性变异。